PRASOLCHEM PRASOLCHEM Q1 FY27 results (Apr–Jun 2026) and concall
Prasol Chemicals' first earnings call after listing covered a strong Q1 FY27: revenue rose 35.7% YoY to ₹433.6 crores, EBITDA rose 122.4% to ₹90.3 crores and PAT rose 151% to ₹61 crores. A large part of the margin jump came from carrying low-cost acetone inventory into the price spike caused by the West Asia conflict (~₹25 crore gain), and management said it expects margins to normalize. FY27 guidance of ₹1,550-1,650 crores revenue and ₹240-250 crores adjusted EBITDA is described as conservative. The growth story rests on a ₹250-300 crore Phase 1 debottlenecking/expansion (+60,000 tons), the M
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q1 FY26 | Q2 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue | 320 | 298 | 335 | 434 |
| EBITDA | 41 | 31 | 32 | 90 |
| Net profit | 24 | 17 | 20 | 61 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
